Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/ARIAD_Pharmaceuticals> ?p ?o }
- ARIAD_Pharmaceuticals abstract "ARIAD Pharmaceuticals, Inc. is an oncology company founded in 1991 and headquartered in Cambridge, Massachusetts. On December 14, 2012 the FDA approved Ariad Pharmaceutical’s leukemia drug Iclusig for patients with all forms of chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia who are resistant or unable to tolerate other tyrosine kinase therapies on the market.".
- ARIAD_Pharmaceuticals assets "50.4".
- ARIAD_Pharmaceuticals foundingYear "1991".
- ARIAD_Pharmaceuticals industry Biotechnology.
- ARIAD_Pharmaceuticals industry Pharmaceutical_industry.
- ARIAD_Pharmaceuticals location Cambridge,_Massachusetts.
- ARIAD_Pharmaceuticals location United_States.
- ARIAD_Pharmaceuticals netIncome "85.25".
- ARIAD_Pharmaceuticals numberOfEmployees "125".
- ARIAD_Pharmaceuticals operatingIncome "104.9".
- ARIAD_Pharmaceuticals product Brigatinib.
- ARIAD_Pharmaceuticals product Ponatinib.
- ARIAD_Pharmaceuticals product Ridaforolimus.
- ARIAD_Pharmaceuticals revenue "178.98".
- ARIAD_Pharmaceuticals type Public_company.
- ARIAD_Pharmaceuticals wikiPageExternalLink www.ariad.com.
- ARIAD_Pharmaceuticals wikiPageID "20737471".
- ARIAD_Pharmaceuticals wikiPageLength "5328".
- ARIAD_Pharmaceuticals wikiPageOutDegree "33".
- ARIAD_Pharmaceuticals wikiPageRevisionID "673654677".
- ARIAD_Pharmaceuticals wikiPageWikiLink Biotechnology.
- ARIAD_Pharmaceuticals wikiPageWikiLink BlackRock.
- ARIAD_Pharmaceuticals wikiPageWikiLink Brigatinib.
- ARIAD_Pharmaceuticals wikiPageWikiLink Bristol-Myers_Squibb.
- ARIAD_Pharmaceuticals wikiPageWikiLink Cambridge,_Massachusetts.
- ARIAD_Pharmaceuticals wikiPageWikiLink Carl_Icahn.
- ARIAD_Pharmaceuticals wikiPageWikiLink Category:1991_establishments_in_Massachusetts.
- ARIAD_Pharmaceuticals wikiPageWikiLink Category:Biotechnology_companies_of_the_United_States.
- ARIAD_Pharmaceuticals wikiPageWikiLink Category:Companies_based_in_Cambridge,_Massachusetts.
- ARIAD_Pharmaceuticals wikiPageWikiLink Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- ARIAD_Pharmaceuticals wikiPageWikiLink Category:Companies_listed_on_NASDAQ.
- ARIAD_Pharmaceuticals wikiPageWikiLink Category:Life_sciences_industry.
- ARIAD_Pharmaceuticals wikiPageWikiLink Category:Merck.
- ARIAD_Pharmaceuticals wikiPageWikiLink Category:Pharmaceutical_companies_established_in_1991.
- ARIAD_Pharmaceuticals wikiPageWikiLink Category:Pharmaceutical_companies_of_the_United_States.
- ARIAD_Pharmaceuticals wikiPageWikiLink File:ARIAD_logo.png.
- ARIAD_Pharmaceuticals wikiPageWikiLink Merck_&_Co..
- ARIAD_Pharmaceuticals wikiPageWikiLink Pfizer.
- ARIAD_Pharmaceuticals wikiPageWikiLink Pharmaceutical_industry.
- ARIAD_Pharmaceuticals wikiPageWikiLink Ponatinib.
- ARIAD_Pharmaceuticals wikiPageWikiLink Public_company.
- ARIAD_Pharmaceuticals wikiPageWikiLink Ridaforolimus.
- ARIAD_Pharmaceuticals wikiPageWikiLink United_States.
- ARIAD_Pharmaceuticals wikiPageWikiLink United_States_dollar.
- ARIAD_Pharmaceuticals wikiPageWikiLinkText "ARIAD Pharmaceuticals".
- ARIAD_Pharmaceuticals wikiPageWikiLinkText "Ariad Pharmaceuticals".
- ARIAD_Pharmaceuticals wikiPageWikiLinkText "Ariad".
- ARIAD_Pharmaceuticals wikiPageWikiLinkText "by Ariad".
- ARIAD_Pharmaceuticals assets "US$50.4M".
- ARIAD_Pharmaceuticals foundation "1991".
- ARIAD_Pharmaceuticals homepage www.ariad.com.
- ARIAD_Pharmaceuticals industry Biotechnology.
- ARIAD_Pharmaceuticals industry Pharmaceutical_industry.
- ARIAD_Pharmaceuticals keyPeople "Chairman & CEOTimothy P. Clackson,".
- ARIAD_Pharmaceuticals keyPeople "Harvey Berger,".
- ARIAD_Pharmaceuticals keyPeople "President of Research and Development and Chief Scientific Officer".
- ARIAD_Pharmaceuticals location Cambridge,_Massachusetts.
- ARIAD_Pharmaceuticals location United_States.
- ARIAD_Pharmaceuticals logo "151".
- ARIAD_Pharmaceuticals name "ARIAD Pharmaceuticals, Inc.".
- ARIAD_Pharmaceuticals netIncome "US$85.25M".
- ARIAD_Pharmaceuticals numEmployees "125".
- ARIAD_Pharmaceuticals operatingIncome "US$104.90M".
- ARIAD_Pharmaceuticals products Brigatinib.
- ARIAD_Pharmaceuticals products Ponatinib.
- ARIAD_Pharmaceuticals products Ridaforolimus.
- ARIAD_Pharmaceuticals revenue "US$178.98M".
- ARIAD_Pharmaceuticals slogan "Leading the pathway to better cancer therapies".
- ARIAD_Pharmaceuticals type Public_company.
- ARIAD_Pharmaceuticals wikiPageUsesTemplate Template:Decrease.
- ARIAD_Pharmaceuticals wikiPageUsesTemplate Template:Infobox_company.
- ARIAD_Pharmaceuticals wikiPageUsesTemplate Template:NASDAQ.
- ARIAD_Pharmaceuticals wikiPageUsesTemplate Template:Pharmaceutical_companies_of_the_United_States.
- ARIAD_Pharmaceuticals wikiPageUsesTemplate Template:Portal.
- ARIAD_Pharmaceuticals wikiPageUsesTemplate Template:Profit.
- ARIAD_Pharmaceuticals wikiPageUsesTemplate Template:Reflist.
- ARIAD_Pharmaceuticals subject Category:1991_establishments_in_Massachusetts.
- ARIAD_Pharmaceuticals subject Category:Biotechnology_companies_of_the_United_States.
- ARIAD_Pharmaceuticals subject Category:Companies_based_in_Cambridge,_Massachusetts.
- ARIAD_Pharmaceuticals subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- ARIAD_Pharmaceuticals subject Category:Companies_listed_on_NASDAQ.
- ARIAD_Pharmaceuticals subject Category:Life_sciences_industry.
- ARIAD_Pharmaceuticals subject Category:Merck.
- ARIAD_Pharmaceuticals subject Category:Pharmaceutical_companies_established_in_1991.
- ARIAD_Pharmaceuticals subject Category:Pharmaceutical_companies_of_the_United_States.
- ARIAD_Pharmaceuticals type Agent.
- ARIAD_Pharmaceuticals type Company.
- ARIAD_Pharmaceuticals type Organisation.
- ARIAD_Pharmaceuticals type Company.
- ARIAD_Pharmaceuticals type Establishment.
- ARIAD_Pharmaceuticals type Organization.
- ARIAD_Pharmaceuticals type Agent.
- ARIAD_Pharmaceuticals type SocialPerson.
- ARIAD_Pharmaceuticals type Thing.
- ARIAD_Pharmaceuticals type Q43229.
- ARIAD_Pharmaceuticals comment "ARIAD Pharmaceuticals, Inc. is an oncology company founded in 1991 and headquartered in Cambridge, Massachusetts. On December 14, 2012 the FDA approved Ariad Pharmaceutical’s leukemia drug Iclusig for patients with all forms of chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia who are resistant or unable to tolerate other tyrosine kinase therapies on the market.".
- ARIAD_Pharmaceuticals label "ARIAD Pharmaceuticals".
- ARIAD_Pharmaceuticals sameAs Q4653724.
- ARIAD_Pharmaceuticals sameAs m.03p1j62.
- ARIAD_Pharmaceuticals sameAs Q4653724.